Merck & Co Inc
PAR:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck & Co Inc
PAR:MRK
|
US |
|
D
|
Dollarama Inc
XBER:DR3
|
CA |
|
C
|
Cooper Metals Ltd
ASX:CPM
|
AU |
|
Anjoy Foods Group Co Ltd
SSE:603345
|
CN |
|
B
|
Bank Millennium SA
LSE:0DRH
|
PL |
|
Deutsche Cannabis AG
F:HEMP
|
DE |
|
Assure Holdings Corp
OTC:IONM
|
US |
Wall Street
Price Targets
MRK Price Targets Summary
Merck & Co Inc
According to Wall Street analysts, the average 1-year price target for
MRK
is 108.6607 EUR
with a low forecast of 79.9577 EUR and a high forecast of 131.249 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MRK's stock price target?
Price Target
108.6607
EUR
According to Wall Street analysts, the average 1-year price target for
MRK
is 108.6607 EUR
with a low forecast of 79.9577 EUR and a high forecast of 131.249 EUR.
What is Merck & Co Inc's Revenue forecast?
Projected CAGR
5%
For the last 14 years the
compound annual growth rate for
Merck & Co Inc's revenue is
2%.
The projected
CAGR
for the next 3 years is
5%.
What is Merck & Co Inc's Operating Income forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Merck & Co Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
6%.
What is Merck & Co Inc's Net Income forecast?
Projected CAGR
14%
For the last 14 years the
compound annual growth rate for
Merck & Co Inc's net income is
8%.
The projected
CAGR
for the next 3 years is
14%.
